The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) and other violations of state law by the board of directors of Merck & Co., Inc. (“Merck”), in a transaction valued at approximately $3.85 billion. Idenix Pharmaceuticals Inc (NASDAQ:IDIX) weekly performance is 244.78%. On last trading day company shares ended up $23.79. Idenix Pharmaceuticals Inc (NASDAQ:IDIX) distance from 50-day simple moving average (SMA50) is 307.27%.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced the Company has begun dosing ACH-3422, a uridine-analog nucleotide polymerase inhibitor, for seven days in patients with genotype 1 chronic hepatitis C viral infection (HCV) in its ongoing Phase 1 clinical trial. Proof-of-concept results from this trial are expected to be reported during the fall of 2014. Furthermore, Achillion announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on sovaprevir, an NS3/4A protease inhibitor, to permit the conduct of trials in patients with HCV. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares advanced 47.57% in last trading session and ended the day on $4.25. Its return on assets is -37.40%. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) quarterly performance is 28.40%.
Analog Devices Inc. (NASDAQ:ADI) introduced the industry’s highest accuracy isolated sigma-delta modulator for precision current and voltage measurement in DC/AC power conversion applications. Analog Devices, Inc. (NASDAQ:ADI) shares moved up 4.97% in last trading session and was closed at $55.31, while trading in range of $54.28 – $56.18. Analog Devices, Inc. (NASDAQ:ADI) year to date (YTD) performance is 10.16%.
4 insiders sold MannKind Corporation (NASDAQ:MNKD) stock within one month. The stock was not purchased by any insiders in the month of intensive selling. 3 of these 4 insiders decreased their holdings by more than 10%. There have been 639,064 shares sold by insiders during the last 30 days. All these shares were sold pursuant to a Rule 10b5-1 plan. MannKind Corporation (NASDAQ:MNKD) ended the last trading day at $10.70. Company weekly volatility is calculated as 8.12% and price to cash ratio as 116.15. MannKind Corporation (NASDAQ:MNKD) showed a positive weekly performance of 18.49%.
On June 3, Unwired Planet Inc, (NASDAQ:UPIP), announced that Dallas Clement was appointed to the company’s board of directors. Mr. Clement is executive vice president and chief financial officer for Cox Automotive, a $4.4 billion annual revenue worldwide automotive marketplace provider. In this role, Mr. Clement leads all of the company’s finance functions, as well as legal, corporate development, strategy and investor relations activities. Unwired Planet Inc (NASDAQ:UPIP) weekly performance is 9.13%. On last trading day company shares ended up $2.27. Analysts mean target price for the company is $4.50. Unwired Planet Inc (NASDAQ:UPIP) distance from 50-day simple moving average (SMA50) is 7.58%.